TMEM239
TMEM239 | ||||||
---|---|---|---|---|---|---|
Identifiers | ||||||
Ensembl | ||||||
UniProt | ||||||
RefSeq (mRNA) | ||||||
RefSeq (protein) | ||||||
Location (UCSC) | Chr 20: 2.82 – 2.82 Mb | Chr 2: 130.25 – 130.25 Mb | ||||
PubMed search | [3] | [4] |
View/Edit Human | View/Edit Mouse |
Within mammalia, TMEM239 orthologs are found in organisms belonging to
Expression
Based on human expressed sequence tag (EST) profiles, TMEM239 appears to be expressed in the testis and the brain.[5] According to PaxDb, the abundance of TMEM239 falls within the bottom 10% relative to all other proteins in both mice and humans.[6] Overall, expression of TMEM239 is limited. TMEM239 appears to be expressed at moderate levels in the testes, with low expression in a variety of other tissues, including the brain and submaxillary gland.
Interactions
TMEM239 protein interactions appear to be implicated in cell signaling, membrane transport and immunology.
Additional TMEM239 protein interactions were identified through a human interactome mapping project. Synthenein-1 (SDCBP) is involved in the
The Golgi SNAP receptor complex member 1 (GOS1) was found to associate with TMEM239.
Clinical significance
SNP rs7360412, located in the 3’UTR of TMEM239, was identified in a genome-wide association study of quantitative phenotypes for bipolar disorder as a top marker for fractional anisotropy.[12] In this context, fractional anisotropy, as detected by diffusion tensor imaging, was used to assess white matter integrity. White matter integrity is highly heritable and reduced in both bipolar patients and their unaffected relatives.
RNA-seq was used to analyze the transcriptomes of human and Leishmania primary cutaneous lesions, in order to understand differences in host and parasitic factors influencing the progression of Localized Cutaneous Leishmaniasis (LCL) to Mucosal Leishmaniasis (ML).[13] Decreased expression of TMEM239 in a primary cutaneous lesions indicates a higher probability of ML development.
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000198326 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000049692 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Transmembrane protein 239 (TMEM239)". www.ncbi.nlm.nih.gov. Retrieved 2016-02-27.
- ^ "PaxDb". pax-db.org. Retrieved 2016-04-25.
- PMID 22458338.
- ^ "SDCBP - Syntenin-1 - Homo sapiens (Human) - SDCBP gene & protein". www.uniprot.org. Retrieved 2016-04-25.
- PMID 27107014.
- ^ "GOS1 - Golgi SNAP receptor complex member 1 - Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) - GOS1 gene & protein". www.uniprot.org. Retrieved 2016-04-25.
- ^ "TAE1 - Alpha N-terminal protein methyltransferase 1 - Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) - TAE1 gene & protein". www.uniprot.org. Retrieved 2016-04-25.
- S2CID 22967553.
- PMID 23029578.